Dirk Dittmer, PhD, professor of microbiology and immunology at the UNC School of Medicine, is tracking the virus that causes COVID-19 by sequencing the genome of virus samples collected from diagnostic testing. Using next generation sequencing on...
21-Oct-2020 2:05 PM EDT Add to Favorites
Babies born with a faulty maternal copy of the UBE3A gene will develop a severe neurodevelopmental disorder with no cure and limited treatments. Now, scientists show that gene editing/gene therapy techniques can be used to restore UBE3A in human...
20-Oct-2020 4:00 PM EDT Add to Favorites
For the first time, scientists at UNC-Chapel Hill and Stanford solved the high-resolution structure of psychedelic drugs bound to the 5-HT2A serotonin receptor, a major step toward understanding how the drugs cause such wild effects and how they...
15-Sep-2020 5:15 PM EDT Add to Favorites
UNC School of Medicine researchers took striking images of the SARS-CoV-2 virus produced by infected respiratory epithelial cells inside human respiratory tract cultures. The New England Journal of Medicine featured this work in its “Images in...
10-Sep-2020 4:45 PM EDT Add to Favorites
Infection prevention experts at the UNC Medical Center set out to gather evidence on the fitted filtration efficiency of dozens of different types of masks and mask modifications, including masks sterilized for reuse, expired masks, novel masks...
11-Aug-2020 9:00 AM EDT Add to Favorites
This research shows that both Pseudomonas and Burkholderia use toxic weaponry, called Type VI Secretion Systems (T6SS), to compete with and establish dominance over each other. It could be possible to target or mimic this weaponry to defeat the...
7-Aug-2020 3:25 PM EDT Add to Favorites
A study recently published in the journal Circulation looks at temporal trends in the burden of comorbidities and associated risk of mortality among patients with heart failure (HF) with preserved ejection fraction (HFpEF), in which the left...
30-Jul-2020 12:40 PM EDT Add to Favorites
CAR-T cell therapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been used to treat Hodgkin lymphoma with remarkable success for the first time, according to the results of an early phase clinical trial.
23-Jul-2020 5:05 PM EDT Add to Favorites
See All News
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center experts are available to provide expert commentary and feedback on research presented at the AACR Annual Meeting 2018.
13-Apr-2018 10:05 AM EDT
Dr. Thomas Egan of the University of North Carolina School of Medicine says that a recent change in donor lung allocation policy was long overdue. However, because the change happened over the Thanksgiving holiday weekend in response to litigation,...
16-Jan-2018 10:05 AM EST
UNC Health Care and the UNC School of Medicine have launched a tool for media to request interviews with experts and researchers at the forefront of the global Zika research initiative.
12-Jul-2016 9:05 AM EDT
20-Mar-2014 3:00 PM EDT
Experts Available to Discuss NEJM Editorial on Use of PARP Inhibitors in Triple-Negative Breast Cancer
In the editorial, the UNC researchers explain the excitement about this new class of drugs and the importance of this trial. They also highlight the reasons that caution as well as enthusiasm is warranted.
3-Jan-2011 2:50 PM EST
Dr. Darren DeWalt, author of a JAMA editorial being released early online this week, is available for media interviews.
29-Nov-2010 11:45 AM EST
UNC expert available to discuss latest development in search for AIDS vaccine.
24-Sep-2009 12:40 PM EDT
UNC brain surgeon Anand Germanwala, M.D. and ENT surgeon Adam Zanation, M.D., collaborated to develop through-the-nose approach to repair a patient's ruptured brain aneurysm.
26-Aug-2009 9:00 AM EDT